Delivery Order SPE2DB22D3009-SPE2DB25FBD15
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,147.26 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (50-unit dose packaging) on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,177,965 units of the sleep medication Ramelteon 8 mg Tablet 30s. The $1,415.04 contract has a performance period through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,432.06 firm-fixed-price delivery order provides 4566170446 ramelteon 8 mg tablets to support military healthcare programs. The award has an ultimate completion date of October 22, 2024 and was issued on October 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RAMELTEON 8 MG TABLET 30S. The contract has a ceiling value of $1,543.74 and will run through August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,543.17 firm fixed price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication RAMELTEON 8MG TAB 30S. The contract has a firm fixed price of $3,519.16 and a completion date of June 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $407.47 to Amerisourcebergen Drug Corporation under an existing prime vendor contract vehicle. The firm fixed price order is for 4561888114 Ramelteon 8 mg tablets to be delivered by August 22, 2023 from the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime contractor without the use of major subcontractors....
- The Department of Defense's Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 50 units of the pharmaceutical RAMELTEON 8 MG TABLET UD. The $1,999.20 contract has a performance period ending January 11, 2024. AmerisourceBergen Drug Corp, which provides pharmaceutical products and services to U.S. government agencies, including the Department of Defense, has received numerous federal...
- This delivery order for $349 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for 30 tablets of 8 mg ramelteon. The order is for product delivery by October 18, 2023 under a firm fixed price contract. Amerisourcebergen Drug Corp will perform the order from its location in Conshohocken, Pennsylvania. No set-aside provision was specified for this order placed under an existing vehicle by the Defense Logistics Agency to fulfill pharmaceutical needs for the military.
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBD15Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ramelteon 8 mg tablets (100-count units) with a contract ceiling value of $3,606.44. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The ultimate completion date is August 14, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare supply chains. The company maintains extensive contract awards with the Defense Logistics Agency for a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. As a prime vendor under the DLA Troop Support Medical program, AmerisourceBergen provides pharmaceutical support to customers including the Defense Health Agency and U.S. Coast Guard, demonstrating its capability to fulfill federal medical procurement requirements through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/13/25 |